CellSeed withdraws stem cell drug application

Singapore: Europe's CellSeed has withdrawn its application for a centralized marketing authorization for the medicine Or...

March 22, 2013 | Friday | News
Biodiem develops killer for drug-resistant microbes

Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial ...

October 18, 2012 | Thursday | News
Afatinib proves efficacy in lung cancer treatment

Singapore: The LUX-Lung 3 Phase III results showed that lung cancer patients taking the novel compound afatinib, an irre...

June 5, 2012 | Tuesday | News
Openvas by Daiichi Sankyo launched in Mexico

Singapore: Japan-based Daiichi Sankyo has launched antihypertensive franchise olmesartan medoxomil in Mexico under the n...

June 11, 2012 | Monday | News
Osteoporosis is an emerging crisis in APAC: Report

Singapore: A new report, launched by the International Osteoporosis Foundation (IOF), shows that osteoporosis is a loomi...

December 13, 2013 | Friday | Analysis
Genting to acquire 20% equity stake in TauRx

Singapore: Singapore-based TauRx Pharmaceuticals has received equity investment of $31.5 million from Genting Management...

November 20, 2012 | Tuesday | News
Nanotherapeutics seeks GE help to step up development

Singapore: Biopharmaceutical company Nanotherapeutics has selected GE Healthcare Life Sciences' FlexFactory biomanufactu...

January 24, 2014 | Friday | News
Steroid pioneer gets Heritage Foundation, BIO award

Singapore: Chemical Heritage Foundation (CHF) and Biotechnology Industry Organization (BIO) have selected Mexican steroi...

April 22, 2013 | Monday | Influencers
Austrianova starts cell bank for cancer therapy

Singapore: Austrianova Singapore has established a research cell bank, the first step towards late-phase clinical trials...

March 21, 2013 | Thursday | News
Takeda, Dainippon to market schizophrenia drug

Singapore: Japanese companies Dainippon Sumitomo Pharma and Takeda Pharmaceutical have obtained approval for marketing a...

August 13, 2013 | Tuesday | News
Astellas to pay $300 mn for cancer drug conjugates

Singapore: Japan's Astellas Pharma has collaborated with US-based Ambrx for the discovery and development of novel antib...

April 5, 2013 | Friday | News
Jubilant, Janssen expand drug discovery alliance

Singapore: Jubilant Biosys, a subsidiary of Bangalore-based Jubilant Life Sciences, has expanded its drug discovery alli...

February 21, 2014 | Friday | News
Patrys' 2nd group concludes treatment in Germany

Singapore: Patrys completed initial treatment of second group of three patients in its phase I/IIa PAT-SM6 multiple myel...

April 10, 2013 | Wednesday | News
AstraZeneca biologics R&D arm acquires Amplimmune

Singapore: AstraZeneca's global biologics R&D arm, MedImmune, plans to acquire Amplimmune, which is a US-based biolo...

August 27, 2013 | Tuesday | News
Biostar, Shaanxi Uni to co-develop liver cancer drug

Singapore: Biostar Pharmaceuticals, a China-based manufacturer and marketer of pharmaceutical and health supplement prod...

March 7, 2014 | Friday | News
Otsuka schizophrenia relapse gets FDA nod

Singapore: Japan-based Otsuka Pharmaceutical and H Lundbeck have received US FDA approval for Abilify Maintena (aripipra...

March 1, 2013 | Friday | Regulatory
Novogen to develop new class of cancer drugs

Singapore: Australia-based Novogen has acquired a novel drug technology that will be developed as a potentially major cl...

October 9, 2013 | Wednesday | News
FDA issues complete response letter for XARELTO

Singapore: US Food and Drug Administration (FDA) have issued a complete response letter regarding a supplemental New Dru...

June 22, 2012 | Friday | Regulatory